Cargando…

Analysis of the Role of FRMD5 in the Biology of Papillary Thyroid Carcinoma

Background: Thyroid carcinoma (TC) is the most common endocrine system malignancy, and papillary thyroid carcinoma (PTC) accounts for >80% of all TC cases. Nevertheless, PTC pathogenesis is still not fully understood. The aim of the study was to elucidate the role of the FRMD5 protein in the regu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gaweł, Agata M., Ratajczak, Maciej, Gajda, Ewa, Grzanka, Małgorzata, Paziewska, Agnieszka, Cieślicka, Marta, Kulecka, Maria, Oczko-Wojciechowska, Małgorzata, Godlewska, Marlena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268710/ https://www.ncbi.nlm.nih.gov/pubmed/34201607 http://dx.doi.org/10.3390/ijms22136726

Ejemplares similares

The Role of miRNA-7 in the Biology of Cancer and Modulation of Drug Resistance
por: Gajda, Ewa, et al.
Publicado: (2021)

Resolving the role of podoplanin in the motility of papillary thyroid carcinoma-derived cells using RNA sequencing
por: Mielecki, Damian, et al.
Publicado: (2023)

Novel Inhibitor-Based Therapies for Thyroid Cancer—An Update
por: Ratajczak, Maciej, et al.
Publicado: (2021)

TERT Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma
por: Rusinek, Dagmara, et al.
Publicado: (2020)

Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma—Do They Exist?
por: Szpak-Ulczok, Sylwia, et al.
Publicado: (2020)

Cellular and molecular basis of thyroid autoimmunity
por: Bogusławska, Joanna, et al.
Publicado: (2021)

Combinatory Treatment with miR-7-5p and Drug-Loaded Cubosomes Effectively Impairs Cancer Cells
por: Gajda, Ewa, et al.
Publicado: (2020)

Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival
por: Krajewska, Jolanta, et al.
Publicado: (2020)

Therapeutic Strategy in Low-Risk Papillary Thyroid Carcinoma – Long-Term Results of the First Single-Center Prospective Non-Randomized Trial Between 2011 and 2015
por: Czarniecka, Agnieszka, et al.
Publicado: (2021)

Gene signature of the post-Chernobyl papillary thyroid cancer
por: Handkiewicz-Junak, Daria, et al.
Publicado: (2016)

Novel TG‐FGFR1 and TRIM33‐NTRK1 transcript fusions in papillary thyroid carcinoma
por: Pfeifer, Aleksandra, et al.
Publicado: (2019)

Current status of the prognostic molecular markers in medullary thyroid carcinoma
por: Oczko-Wojciechowska, Malgorzata, et al.
Publicado: (2020)

Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?
por: Rusinek, Dagmara, et al.
Publicado: (2017)

Simvastatin Coadministration Modulates the Electrostatically Driven Incorporation of Doxorubicin into Model Lipid and Cell Membranes
por: Bartkowiak, Aleksandra, et al.
Publicado: (2022)

Data Integration–Possibilities of Molecular and Clinical Data Fusion on the Example of Thyroid Cancer Diagnostics
por: Płuciennik, Alicja, et al.
Publicado: (2022)

A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping
por: Fujarewicz, Krzysztof, et al.
Publicado: (2007)

The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAF(V600E) Mutation Status and Other Prognostic Factors
por: Czarniecka, Agnieszka, et al.
Publicado: (2015)

Coexistence of TERT Promoter Mutations and the BRAF V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients
por: Rusinek, Dagmara, et al.
Publicado: (2018)

Extracellular Vesicles as Signal Carriers in Malignant Thyroid Tumors?
por: Grzanka, Małgorzata, et al.
Publicado: (2022)

Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells
por: Di Maro, Gennaro, et al.
Publicado: (2014)

Shared and unique metabolic features of the malignant and benign thyroid lesions determined with use of (1)H HR MAS NMR spectroscopy
por: Skorupa, Agnieszka, et al.
Publicado: (2021)

Molecular Signature of Prospero Homeobox 1 (PROX1) in Follicular Thyroid Carcinoma Cells
por: Rudzińska, Magdalena, et al.
Publicado: (2019)

A gene expression signature distinguishes normal tissues of sporadic and radiation-induced papillary thyroid carcinomas
por: Dom, G, et al.
Publicado: (2012)

Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations
por: Oczko-Wojciechowska, Malgorzata, et al.
Publicado: (2017)

Corrigendum: Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations
por: Oczko-Wojciechowska, Malgorzata, et al.
Publicado: (2017)

The Role of FRMD7 in Idiopathic Infantile Nystagmus
por: Watkins, Rachel J., et al.
Publicado: (2012)

The Anti-Tumoral Potential of Phosphonate Analog of Sulforaphane in Zebrafish Xenograft Model
por: Rudzinska-Radecka, Magdalena, et al.
Publicado: (2021)

Coexistence of papillary thyroid cancer with Hashimoto thyroiditis
por: Konturek, Aleksander, et al.
Publicado: (2012)

Abnormal retinal development associated with FRMD7 mutations
por: Thomas, Mervyn G., et al.
Publicado: (2014)

Correlations of FRMD7 gene mutations with ocular oscillations
por: Huang, Lijuan, et al.
Publicado: (2022)

Identification of a novel FRMD7 splice variant and functional analysis of two FRMD7 transcripts during human NT2 cell differentiation
por: Li, Yingzhi, et al.
Publicado: (2011)

Differences in miRNA and mRNA Profile of Papillary Thyroid Cancer Variants
por: Stokowy, Tomasz, et al.
Publicado: (2016)

Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours
por: Wojtas, Bartosz, et al.
Publicado: (2017)

Mutation Profiling of Premalignant Colorectal Neoplasia
por: Karczmarski, Jakub, et al.
Publicado: (2019)

Trastuzumab-Modified Gold Nanoparticles Labeled with (211)At as a Prospective Tool for Local Treatment of HER2-Positive Breast Cancer
por: Dziawer, Łucja, et al.
Publicado: (2019)

Novel mutations of FRMD7 in Chinese patients with congenital motor nystagmus
por: Jia, Xiuhua, et al.
Publicado: (2017)

Biochemical properties of thyroid peroxidase (TPO) expressed in human breast and mammary-derived cell lines
por: Godlewska, Marlena, et al.
Publicado: (2018)

Molecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues
por: Pfeifer, Aleksandra, et al.
Publicado: (2013)

A FRMD7 variant in a Japanese family causes congenital nystagmus
por: Kohmoto, Tomohiro, et al.
Publicado: (2015)

New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing
por: Kluska, Anna, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mkuj5ph677ki7ad5dlb4s412pt